Webinar: Meine Gedanken zu The Big Call: Geeignete Aktien für Hebel-Trades auf Sicht von 2 Jahren!

Avadel Pharmaceuticals Aktie

Watchlist AVDL WKN A2DJR8 ISIN US05337M1045

Was macht Avadel Pharmaceuticals?

Unternehmensprofil
Unternehmensprofil

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Chart der Avadel Pharmaceuticals Aktie

Charttool öffnen

Aktuelle Nachrichten zu Avadel Pharmaceuticals

Weitere Nachrichten

Das berichten andere über Avadel Pharmaceuticals